Alexandru Stieber/LinkedIn
Dec 1, 2025, 15:32
Alexandru Stieber on a Curious Finding: GLP-1 RAs and the Risk of Optic Neuropathy
Alexandru Stieber, Internal Medicine Resident at SUUMC Bucharest, posted on LinkedIn:
“A very curious research revealing a possible link between the use of GLP-1 receptor antagonists such as semaglutide or liraglutide and the risk of developing nonarteritic ischemic anterior optic neuropathy, current findings which support previous studies on the matter and that nuance the uses of such therapeutic agents.”
Title: GLP-1 RAs and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Older Patients With Diabetes
Authors: Kin Wah Fung, Fitsum Baye, Seo H. Baik, Clement J. McDonald
Read full article here.
Stay updated with Hemostasis Today.
-
Mar 2, 2026, 17:22Hematologists and Oncologists Recognize Their Role in Specialized VA Care Despite Ongoing Knowledge Gaps – JTH
-
Mar 2, 2026, 17:04Fernando Corrales-Medina: An Evidence-Based Platform Promoting Early Recognition and Evaluation of VWD
-
Mar 2, 2026, 16:56Mbunya S. Misiani: Changing the Narrative on Bleeding Disorders Across Africa
-
Mar 2, 2026, 16:51Ofoke Chiamaka: Rehabilitation Is Not Just Muscle Training, It Is Brain Retraining
-
Mar 2, 2026, 16:41Paul Bolaji: Beyond Acute Stroke Care – Independent Integrated Living After Stroke
-
Mar 2, 2026, 16:37Gianluca Franceschini: Precision Medicine Is Only Truly Effective If It Is Inclusive
-
Mar 2, 2026, 16:34Maha Othman: Calling a Guest Editor for Current Opinion in Hematology
-
Mar 2, 2026, 16:30Tareq Abadl: Erythropoiesis – The Cellular Engineering Behind Oxygen Delivery
-
Mar 2, 2026, 16:28Tagreed Alkaltham: Blood Management in Times of Crisis